Financhill
Back

Structure Therapeutics, Inc. Stock Price Chart

  • Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and GPCR is experiencing slight buying pressure.

Structure Therapeutics, Inc. Price Chart Indicators

Moving Averages Level Buy or Sell
8-day SMA: 38.22 Buy
20-day SMA: 36.44 Buy
50-day SMA: 32.1 Buy
200-day SMA: 23.71 Buy
8-day EMA: 41.78 Buy
20-day EMA: 37.11 Buy
50-day EMA: 32.59 Buy
200-day EMA: 27.3 Buy

Structure Therapeutics, Inc. Technical Analysis Indicators

Chart Indicators Level Buy or Sell
MACD (12, 26): 3.48 Buy
Relative Strength Index (14 RSI): 86.01 Buy
Chaikin Money Flow: 124529 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (28.63 - 42.89) Buy
Bollinger Bands (100): (18.11 - 33.75) Buy

Structure Therapeutics, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Technical Analysis for Structure Therapeutics, Inc. Stock

Is Structure Therapeutics, Inc. Stock a Buy?

GPCR Technical Analysis vs Fundamental Analysis

Sell
45
Structure Therapeutics, Inc. (GPCR) is a Sell

Is Structure Therapeutics, Inc. a Buy or a Sell?

Structure Therapeutics, Inc. Stock Info

Market Cap:
4B
Price in USD:
69.98
Share Volume:
19.5M

Structure Therapeutics, Inc. 52-Week Range

52-Week High:
94.90
52-Week Low:
13.22
Sell
45
Structure Therapeutics, Inc. (GPCR) is a Sell

Structure Therapeutics, Inc. Share Price Forecast

Is Structure Therapeutics, Inc. Stock a Buy?

Fundamental Analysis of Structure Therapeutics, Inc.

Is Structure Therapeutics, Inc. a good investment?

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.49 per share, and a decrease next year of $0.15 per share.

Technical Analysis of Structure Therapeutics, Inc.

Should I short Structure Therapeutics, Inc. stock?

* Structure Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.